Adam Bucki
Uniwersytet Jagiellonski
H-index: 21
Europe-Poland
Top articles of Adam Bucki
Neuroprotective Activity of Enantiomers of Salsolinol and N-Methyl-(R)-salsolinol: In Vitro and In Silico Studies
ACS omega
2023/10/5
Comparative study on ABCB1-dependent efflux of anthracyclines and their metabolites: consequences for cancer resistance
Xenobiotica
2023/7/3
Kamil Piska
H-Index: 10
Adam Bucki
H-Index: 16
Application of automated machine learning in the identification of multi‐target‐directed ligands blocking PDE4B, PDE8A, and TRPA1 with potential use in the treatment of asthma …
Molecular Informatics
2023/7
Adam Bucki
H-Index: 16
Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer’s disease
Bioorganic & Medicinal Chemistry
2023/6/6
In silico and in vitro assessment of carbonyl reductase 1 inhibition using ASP9521—A potent aldo-keto reductase 1C3 inhibitor with the potential to support anticancer therapy …
Molecules
2023/4/27
Kamil Piska
H-Index: 10
Adam Bucki
H-Index: 16
Dual Molecules Targeting 5-HT6 and GABA-A Receptors as a New Approach to Combat Depression Associated with Neuroinflammation
ACS Chemical Neuroscience
2023/4/4
Hybrid molecules combining GABA-A and serotonin 5-HT6 receptors activity designed to tackle neuroinflammation associated with depression
European Journal of Medicinal Chemistry
2023/2/5
Monika Marcinkowska
H-Index: 15
Adam Bucki
H-Index: 16
Paweł Żmudzki
H-Index: 4
Marcin Kolaczkowski
H-Index: 19
The use of machine learning-based sequential virtual screening in the search of new ligands of 5-HT6 receptor
Farmacja Polska
2022
Adam Bucki
H-Index: 16
Cinnamamide derivatives with 4-hydroxypiperidine moiety enhance effect of doxorubicin to cancer cells and protect cardiomyocytes against drug-induced toxicity through CBR1 …
Life Sciences
2022/9/15
Serotonin 5-HT6 Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity—Design, Synthesis and Biological Evaluation of …
International Journal of Molecular Sciences
2022/8/21
Structural Modeling of TRPA1 Ion Channel—Determination of the Binding Site for Antagonists
Molecules
2022/5/11
Adam Bucki
H-Index: 16
Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A (PDE10A) inhibitors and serotonin ligands targeting neuropsychiatric …
European Journal of Medicinal Chemistry
2022/4/5
Adam Bucki
H-Index: 16
Anna Jaromin
H-Index: 12
Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with β-amyloid anti-aggregation properties
European Journal of Medicinal Chemistry
2021/12/5
Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties against amyloid-beta and tau
European Journal of Medicinal Chemistry
2021/12/5
Novel serotonin 5-HT2A receptor antagonists derived from 4-phenylcyclohexane-5-spiro-and 5-methyl-5-phenyl-hydantoin, for use as potential antiplatelet agents
Pharmacological Reports
2021/10
Adam Bucki
H-Index: 16
Maciej Pawłowski
H-Index: 3
Indole and benzimidazole derivatives as dual 5-ht2a and 5-ht6 receptor antagonists
2021/9/9
Multifunctional arylsulfone and arylsulfonamide-based ligands with prominent mood-modulating activity and benign safety profile, targeting neuropsychiatric symptoms of dementia
Journal of Medicinal Chemistry
2021/8/26
Carbonyl reduction pathway in hepatic in vitro metabolism of anthracyclines: Impact of structure on biotransformation rate
Toxicology letters
2021/5/15
New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases
European Journal of Medicinal Chemistry
2021/1/1
In Vitro and In Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases
ACS chemical neuroscience
2020/11/3
